Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells
2024
Correction on CDK4/6 inhibitors and lenvatinib in liver cancer cells
publication
Author Information
Author(s): Digiacomo Graziana, Fumarola Claudia, La Monica Silvia, Bonelli Mara, Cavazzoni Andrea, Galetti Maricla, Terenziani Rita, Eltayeb Kamal, Volta Francesco, Zoppi Silvia, Bertolini Patrizia, Missale Gabriele, Alfieri Roberta, Petronini Pier Giorgio
Primary Institution: University of Parma
Conclusion
The errors in the figures do not change the scientific conclusions of the original article.
Supporting Evidence
- The original article has been updated to correct the figures.
- Errors in the figures were due to images being inserted incorrectly during manuscript preparation.
- The corrected figures do not alter the conclusions of the study.
Takeaway
The study corrected some images in a previous article about cancer treatment, but the main findings remain the same.
Methodology
The study involved treating liver cancer cells with various drug combinations and assessing their effects on cell proliferation and colony formation.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website